Using high-throughput screening data to discriminate compounds with single-target effects from those with side effects.
Authors | |
Keywords | |
Abstract | The most desirable compound leads from high-throughput assays are those with novel biological activities resulting from their action on a single biological target. Valuable resources can be wasted on compound leads with significant 'side effects' on additional biological targets; therefore, technical refinements to identify compounds that primarily have effects resulting from a single target are needed. This study explores the use of multiple assays of a chemical library and a statistic based on entropy to identify lead compound classes that have patterns of assay activity resulting primarily from small molecule action on a single target. This statistic, called the coincidence score, discriminates with 88% accuracy compound classes known to act primarily on a single target from compound classes with significant side effects on nonhomologous targets. Furthermore, a significant number of the compound classes predicted to have primarily single-target effects contain known bioactive compounds. We also show that a compound's known biological target or mechanism of action can often be suggested by its pattern of activities in multiple assays. |
Year of Publication | 2006
|
Journal | J Chem Inf Model
|
Volume | 46
|
Issue | 4
|
Pages | 1549-62
|
Date Published | 2006 Jul-Aug
|
ISSN | 1549-9596
|
DOI | 10.1021/ci050495h
|
PubMed ID | 16859287
|
Links | |
Grant list | R01 HG0017115 / HG / NHGRI NIH HHS / United States
R01 HG003224 / HG / NHGRI NIH HHS / United States
U01 HL81341 / HL / NHLBI NIH HHS / United States
|